Forgot Password?
No Biogen studies can be accessed or new submission completed at this time
Biogen Medical Research Submission Portal is no longer accepting new registrations
No Biogen studies can be accessed or new submissions completed from this portal and you will receive further details directly from Biogen.

Welcome to Biogen's Worldwide Medical Research Submission Portal

This website will enable you to submit your Investigator Initiated Trial proposal for review, track the progress of your existing proposal, and report on ongoing studies.

Submit your research proposal today

Study proposals are submitted to Biogen through this online submission portal. Our review process and considerations for your proposal are outlined below. For detailed information on how to prepare your proposal, submission requirements, and to check on upcoming submission deadlines, please visit the Worldwide Medical Research website at
Biogen supports research in a number of therapeutic areas. A complete study proposal must be submitted to Biogen for review by our cross-functional committee. It should contain a well thought out study rationale, clear primary objective with supportive endpoints, cohesive study design, statistical analysis plan and sample size calculation, and study and publication timelines. For research requesting financial support, an itemized budget on Biogen's template (Clinical Budget Template downloadable here ,Non-Clinical Budget Template downloadable here ) must be provided with the proposal.
For detailed information on how to prepare and submit your proposal, please refer to the instructions outlined in the Proposal Submission Guides. The abbreviate guide will inform you of the required information and details needed to ensure a timely review. These can be found under the "Forms and Instructions" section at the bottom left side of the Visiontracker login window.
Biogen awards research support on a highly competitive basis. All proposals are reviewed by a cross-functional Review Committee, which includes medical directors, drug safety, scientists, biostatisticians, and experts in health outcomes and pharmacoeconomics.